OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
An intranasal vaccine durably protects against SARS-CoV-2 variants in mice
Ahmed O. Hassan, Swathi Shrihari, Matthew J. Gorman, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 6
Ahmed O. Hassan, Swathi Shrihari, Matthew J. Gorman, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 6
Showing 6 citing articles:
SARS-CoV-2 Causes Lung Infection without Severe Disease in Human ACE2 Knock-In Mice
Emma S. Winkler, Rita E. Chen, Fahmida Alam, et al.
Journal of Virology (2021) Vol. 96, Iss. 1
Open Access | Times Cited: 72
Emma S. Winkler, Rita E. Chen, Fahmida Alam, et al.
Journal of Virology (2021) Vol. 96, Iss. 1
Open Access | Times Cited: 72
The Vaccine World of COVID-19: India’s Contribution
Vivek P. Chavda, Disha R. Vihol, Hetvi K. Solanki, et al.
Vaccines (2022) Vol. 10, Iss. 11, pp. 1943-1943
Open Access | Times Cited: 16
Vivek P. Chavda, Disha R. Vihol, Hetvi K. Solanki, et al.
Vaccines (2022) Vol. 10, Iss. 11, pp. 1943-1943
Open Access | Times Cited: 16
Adenoviral-vectored next-generation respiratory mucosal vaccines against COVID-19
Sam Afkhami, Alisha Kang, Vidthiya Jeyanathan, et al.
Current Opinion in Virology (2023) Vol. 61, pp. 101334-101334
Open Access | Times Cited: 9
Sam Afkhami, Alisha Kang, Vidthiya Jeyanathan, et al.
Current Opinion in Virology (2023) Vol. 61, pp. 101334-101334
Open Access | Times Cited: 9
Single-dose respiratory mucosal delivery of next-generation viral-vectored COVID-19 vaccine provides robust protection against both ancestral and variant strains of SARS-CoV-2
Sam Afkhami, Michael R. D’Agostino, Ali Zhang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 4
Sam Afkhami, Michael R. D’Agostino, Ali Zhang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 4
BCG administration promotes the long-term protection afforded by a single-dose intranasal adenovirus-based SARS-CoV-2 vaccine
Dilhan J. Perera, Pilar Domenech, George Babuadze, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Dilhan J. Perera, Pilar Domenech, George Babuadze, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
A bacteriophage-based, highly efficacious, needle and adjuvant-free, mucosal COVID-19 vaccine
Jingen Zhu, Swati Jain, Jian Sha, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
Jingen Zhu, Swati Jain, Jian Sha, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
